Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130211001M |
| Application |
Bone Metabolism |
The kit has been designed for the quantitative determination of Intact Parathyroid hormone (Intact PTH) in human serum. The method can be used for samples over the range of 0-5000 pg/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus and new developed models).
High Precision and StandardizationThe MAGLUMI Intact PTH (CLIA) reagents provide clinicians with precise iPTH quantification for diagnostic accuracy. Results are standardized to the WHO 1st IS 88/642 reference, ensuring consistency across different laboratories and patient populations. This reliability supports effective patient management and informed clinical decisions.
User-Friendly and Automated OperationDesigned for full automation with MAGLUMI Series Analyzers, the kit streamlines laboratory workflow, reducing manual handling and minimizing error. The ready-to-use format and automatic 2-point calibration facilitate fast setup and efficient testing, making it ideal for high-throughput clinical environments.
Comprehensive Diagnostic CapabilitiesWith a wide measurement range and high sensitivity, the MAGLUMI Intact PTH assay can detect both low and high iPTH concentrations, accommodating diverse clinical needs. Its rapid turnaround time and robust performance make it a reliable tool for diagnosing and monitoring parathyroid-related disorders.
FAQ's of Snibe MAGLUMI Intact PTH (CLIA):
Q: How does the Snibe MAGLUMI Intact PTH (CLIA) assay work?
A: The assay utilizes a sandwich chemiluminescence immunoassay technique, where iPTH in the sample binds to specific antibodies, producing a chemiluminescent signal proportional to the concentration of iPTH. The process is fully automated when used with MAGLUMI Series Analyzers.
Q: What samples are required and how much volume is needed for the test?
A: You can use either serum or EDTA plasma for testing. A sample volume of 50 L per test is required to perform the assay.
Q: When is it appropriate to perform an iPTH measurement using this kit?
A: iPTH measurement is recommended when evaluating parathyroid function, diagnosing hyperparathyroidism or hypoparathyroidism, and monitoring related therapeutic interventions.
Q: Where should the MAGLUMI Intact PTH (CLIA) kit be stored?
A: The kit should be stored at 2-8C to maintain reagent stability and ensure optimal performance throughout its 1-year shelf life.
Q: What is the process for calibration and quality control?
A: The kit includes a 2-point calibration and supports multi-point calibration curves. Calibration ensures accuracy and traceability to international standards; always follow the recommended calibration procedures before use.
Q: What are the main benefits of using this iPTH assay kit?
A: Key benefits include high sensitivity and specificity, wide measurement range, rapid turnaround times, and results standardized to the WHO 1st IS 88/642. The automated and ready-to-use design enhances laboratory efficiency and minimizes hands-on time.
Q: Who can use the Snibe MAGLUMI Intact PTH (CLIA) reagent kit?
A: This kit is intended for use by trained personnel in clinical laboratories and hospitals, specifically for quantitative determination of iPTH in human serum or plasma using MAGLUMI Series Analyzers.